November 21, 2026

Pancreatic Cancer Treatment Shows Promise with Experimental Drug

A groundbreaking development in the treatment of pancreatic cancer has emerged with the analysis of clinical trials conducted by Dr. Monique Yohanan on the drug Rasonque from Revolution Medicines. The trial revealed that patients with stage 4 pancreatic cancer experienced a median survival of 13.2 months, a significant improvement from the 6.7 months survival with […]

November 19, 2026

Rising Endometrial Cancer Cases Among Young Women: Key Findings and Implications

Endometrial cancer cases are surging among young women, with significant increases noted among Native American and Hispanic groups. Researchers at the University of Arizona Cancer Center identified a worrying trend: these women are being diagnosed with endometrial cancer at much younger ages compared to other racial and ethnic groups. Disparities in Healthcare and Socioeconomic Status […]

November 17, 2026

Study Uncovers Differences in Pancreatic Tumors Among Racial Groups

A study by the University of Cincinnati has identified variations in pancreatic tumors which might explain why the disease impacts some patients differently. This could lead to more personalized treatment approaches for pancreatic cancer. Researchers analyzed 22 pancreatic tumors from patients with differing racial backgrounds across the United States, focusing on differences in cancer cells […]

November 16, 2026

Spironolactone’s Role in Stroke Recovery

Research indicates that a cost-effective medication might assist stroke survivors with high blood pressure. The study, known as the REDUCE trial, examined if spironolactone, a water pill, could aid in lowering blood pressure post-stroke. The American Heart Association’s Scientific Sessions in Chicago, held from November 6-9, 2026, presented these findings. Study Overview Participants were divided […]

November 12, 2026

Reasons for Discontinuing GLP-1 Medications and Potential Risks

GLP-1 medications such as Ozempic, Wegovy, and Zepbound have transformed weight management and diabetes treatment. However, studies reveal that many patients discontinue them within a year. Ceasing these medications can lead to potential rebound risks, including rapid weight regain and the loss of cardiovascular benefits. Reasons for Stopping Medication Patients may cease taking GLP-1 medications […]

November 12, 2026

Gene CASS4’s Role in Alzheimer’s Disease Progression

A gene associated with Alzheimer’s, known as CASS4, has been linked to vulnerabilities affecting the brain’s immune cells. This discovery provides researchers with a new potential target for therapies aimed at slowing Alzheimer’s progression, as per a recent study conducted on mice. John Lukens, the director at the University of Virginia’s Harrison Family Translational Research […]

November 12, 2026

Research Sheds Light on Obesity Differences between Genders

Studies have long suggested obesity impacts men and women differently. New research may provide an explanation. A study from the University of California, Riverside, observed distinct behaviors of immune cells in male and female mice. Key Findings Researchers discovered a specific kind of immune cell, the eosinophil, acts differently in male and female mice. Traditionally, […]

November 7, 2026

Experimental Drug for Heart Attacks and Strokes Falls Short

An experimental drug, once hoped to be the next significant advance in preventing heart attacks and strokes, has failed a crucial test, researchers announced. The medicine, designed to lower levels of a blood particle linked to heart attacks and strokes, did not protect study participants. Steven Nissen, a cardiologist at the Cleveland Clinic who led […]

November 2, 2026

Immature Brain Cells May Hold Key to Alzheimer’s Cognitive Resilience

Some individuals exhibit the signs of Alzheimer’s in their brains but do not develop dementia. A study in Cell Stem Cell may provide answers to this phenomenon. Researchers examined postmortem human brain tissue and found a population of ‘immature’ neurons linked to cognitive resilience. These neurons might help some people maintain normal cognitive functions despite […]

November 2, 2026

Testosterone Therapy Risks for Postmenopausal Women

Postmenopausal women who use testosterone therapy could face an increased risk of cardiovascular problems, according to recent research. This study was presented at The Menopause Society’s 2026 annual meeting in San Diego and involved over 6,000 women aged 45 and older. These women were compared based on whether they received testosterone therapy or not, excluding […]